CLINICAL_TRIALS
trial_result
· 2021-12-03
Clinical Trial Update: Phase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E) [Phase 3]
Summary
Phase III study of idebenone in Duchenne Muscular Dystrophy was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Santhera Pharmaceuticals | Conditions: Duchenne Muscular Dystrophy | Phase 3 | Status: TERMINATED